GIST Clinical Trial
Official title:
Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm) :a Randomized Controlled Trial
Data are currently insufficient to guide the management of very small gastrointestinal stromal tumors（GISTs）（< 2 cm) discovered incidentally on endoscopy,this study is designed to collect the medical records of patients in different treatment group with long-term follow-up data,and attempts to evaluate the usefulness of regular endoscopic ultrasound（EUS）surveillance and the necessity,safety and feasibility of endoscopic submucosal dissection（ESD）for small GISTs,thus provide evidence for the revision of the guideline.
OBJECTION:to evaluate the usefulness of regular endoscopic ultrasound（EUS） surveillance and
the necessity,safety and feasibility of endoscopic submucosal dissection（ESD） for small
GISTs(<2cm),thus providing evidences for the revision of the guideline.
OUTLINE:This is a randomized controlled trial. Eligible patients are divided into 2 group
with 45 in each.The experimental group undergo ESD for GISTs,while the investigators do no
treatment to the control group.Then,the 2 groups will be follow up for 5 years.All data are
analysed with the Statistical Product and Service Solutions（SPSS）statistical software.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05957367 -
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies
|
Phase 1/Phase 2 | |
| Completed |
NCT01770405 -
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
|
N/A | |
| Active, not recruiting |
NCT03556384 -
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
|
Phase 2 | |
| Recruiting |
NCT05895942 -
Exploring the Molecular Mechanism Based on KIT Mutation
|
||
| Completed |
NCT01459757 -
Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
|
N/A | |
| Completed |
NCT00979381 -
Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor
|
N/A | |
| Completed |
NCT00399152 -
Perifosine + Sunitinib Malate for Patients With Advanced Cancers
|
Phase 1 | |
| Recruiting |
NCT03715933 -
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
|
Phase 1 | |
| Completed |
NCT04599660 -
Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)
|
||
| Completed |
NCT05400018 -
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
|
||
| Recruiting |
NCT03475953 -
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT04825470 -
Liver Transplantation for Unresectable GIST Liver Metastases
|
N/A | |
| Recruiting |
NCT00687778 -
11C-Acetate PET/CT Non-FDG-Avid Tumors
|
N/A | |
| Completed |
NCT00979329 -
Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST
|
N/A | |
| Active, not recruiting |
NCT04927260 -
French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients
|
||
| Completed |
NCT03465722 -
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST
|
Phase 3 | |
| Completed |
NCT03880617 -
Distress, Medication Adherence and Care Needs in Patients With CML and GIST Receiving Oral Targeted Therapy
|
||
| Recruiting |
NCT03896958 -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
|
||
| Completed |
NCT01323400 -
Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)
|
Phase 2 | |
| Recruiting |
NCT05804331 -
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
|